Table 4.
HbA1C Value >9%
|
LDL-C Value ≥ 130 mg/dL
|
Logistic Regression on HbA1C Value >9%
|
||||
---|---|---|---|---|---|---|
% | 95% CI | % | 95% CI | AOR | 95% CI | |
All | 25 | 23–27 | 30 | 27–33 | ||
Race/ethnicity | a | |||||
White | 20 | 8–23 | 29 | 25–32 | ||
African American | 34 | 30–38 | 33 | 28–37 | 1.92*** | 1.47–2.49 |
Latina | 30 | 17–44 | 31 | 18–44 | 1.63 | 0.84–3.14 |
Age (y) | a | |||||
<45 | 30 | 25–34 | 33 | 28–39 | ||
45–49 | 24 | 19–29 | 31 | 26–37 | 0.77 | 0.56–1.08 |
50–54 | 25 | 20–30 | 28 | 22–34 | 0.88 | 0.62–1.25 |
55–59 | 23 | 16–28 | 28 | 21–36 | 0.80 | 0.52–1.22 |
60–64 | 18 | 12–24 | 25 | 18–32 | 0.68 | 0.42–1.10 |
Marital status | ||||||
Married | 25 | 22–29 | 30 | 26–35 | ||
Single | 24 | 19–29 | 31 | 26–37 | 0.87 | 0.63–1.22 |
Divorced/separated | 27 | 23–30 | 29 | 25–34 | 1.04 | 0.78–1.39 |
Widowed | 19 | 10–28 | 29 | 17–40 | 0.85 | 0.43–1.65 |
Physical comorbidity (CCI) | a | 0.97 | 0.82–1.15 | |||
None | 22 | 9–36 | 36 | 22–50 | ||
Low (1–2) | 26 | 23–28 | 32 | 28–35 | ||
Moderate (3–4) | 25 | 20–29 | 25 | 19–31 | ||
Severe (≥5) | 20 | 11–29 | 23 | 12–34 | ||
Psychiatric comorbidity | ||||||
Yes | 26 | 23–30 | 30 | 25–34 | 0.89 | 0.69–1.15 |
No | 24 | 21–27 | 30 | 27–34 | ||
Medicare utilization | ||||||
None | 25 | 23–28 | 30 | 27–33 | ||
>0–<25% | 22 | 13–30 | 26 | 16–36 | ||
25–<75% | 24 | 16–32 | 36 | 25–47 | 1.26 | 0.78–2.02 |
≥75% | 26 | 13–39 | 31 | 15–47 | 1.36 | 0.67–2.77 |
Source of disability identification | a | |||||
Medicare | 23 | 18–27 | 28 | 23–33 | ||
Medicare and VA | 24 | 19–29 | 33 | 27–39 | 0.98 | 0.67–1.42 |
VA | 27 | 24–30 | 30 | 26–34 | 1.11 | 0.79–1.56 |
Notes: Based on veteran women with diagnosed diabetes, aged <65 years who were alive as of the end of fiscal 2000 and qualified for either Medicare or VHA health insurance through disability.
Abbreviations: AOR, adjusted odds ratios; HbA 1C, hemoglobin A1C; LDL-C, low-density lipoprotein cholesterol; CCI, Charlson comorbidity index.
Significant association of individual independent variable and process of care measures based on χ2 tests. Asterisks represent significant group differences in intermediate outcomes. The regressions also include intercepts. In multivariate analyses, the continuous scale of physical comorbidity was used as a predictor. ‘“None” and “>0–<25%” groups were combined in the Medicare utilization variable for the logistic regression analysis.
.05 ≤ p < .10.
.01 ≤ p < .05.
p < .01.